These success, along with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 aid the notion of focusing on ACKR3 as a novel solution to modulate the opioid process, which could open up new therapeutic avenues for opioid-associated disorders. These success suggest that https://louisy390aqd2.blog-mall.com/profile